L-arginine-NO-cGMP signalling pathway in pancreatitis
L-arginine-NO-cGMP, pancreatitis, Pankreatitis
Buchwalow I, et al. L-arginine-NO-cGMP signalling pathway in pancreatitis. Sci Rep 2013;3:1899. doi:10.1038/srep01899
Therapiestandards und Perspektiven beim nichtkleinzelligen Lungenkarzinom im Stadium IV
BRCA beim NSCLC, BRCA in NSCLC, NSCLC testalgorithm, NSCLC-Testalgorithmus, Targeted therapy, TKI-Therapie
Reck M, et al. Therapiestandards und Perspektiven beim nichtkleinzelligen Lungenkarzinom im Stadium IV. Onkologie 2012; 35(Suppl 3):10–13. doi:10.1159/000338986
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer–results from the GeparQuattro study (GBG 40)
GeparQuattro Studie, GeparQuattro study, HER2, Trastuzumab
Minckwitz G, et al. Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer–results from the GeparQuattro study (GBG 40). Breast Cancer Res Treat 2011 Apr;132(3):863-70. doi:10.1007/s10549-011-1621-0
One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group
Lymphknotenmetastasen Mamma-Karzinom, Lymphnode metastasis breast cancer, One Step nucleic acid amplification (OSNA), PCR-Diagnostik
Schem C, et al. One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group. Virchows Arch 2009 Feb;454(2):203-10. doi:10.1007/s00428-008-0703-9
One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group
Lymphknotenmetastasen Mamma-Karzinom, Lymphnode metastasis breast cancer, One Step nucleic acid amplification (OSNA), PCR-Diagnostik
Schem C, et al. One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group. Virchows Arch 2009 Feb;454(2):203-10. doi:10.1007/s00428-008-0703-9
Solid pseudopapillary neoplasms of the pancreas show an interruption of the Wnt-signaling pathway and express gene products of 11q
Cyclin D1, Cyklin D1, FLI1, Psedopapilläre Neoplasie, Solid pseudipapilary neoplams, SPN, WNT signalling, WNT-Signalweg
Tiemann K, et al. Solid pseudopapillary neoplasms of the pancreas show an interruption of the Wnt-signaling pathway and express gene products of 11q. Mod Pathol 2007 Sep;20(9):955-60. doi:10.1038/modpathol.3800902
Solid pseudopapillary neoplasms of the pancreas are associated with FLI-1 expression, but not with EWS/FLI-1 translocation
EWS/FLI-1 translocation, Psedopapilläre Neoplasie, Solid pseudipapilary neoplams, SPN
Tiemann K, et al . Solid pseudopapillary neoplasms of the pancreas are associated with FLI-1 expression, but not with EWS/FLI-1 translocation. Mod Pathol 2006 Nov;19(11):1409-13. doi:10.1038/modpathol.3800664
Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis
Ductal pancreatic adenocarcinoma, Duktales pankreatisches Adenokarzinom, Lymphangiogenese, Lymphangiogenesis
Sipos B, et al. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. J Pathol 2005 Nov;207(3):301-12. doi:10.1002/path.1840
Detection of ESR1 Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients
Borkar, S.; Markus, F.; Oetting, A.; Schmidt, S.; Vössing, C.; Horst, D.; Möbs, M.; Braicu, E.I.; Griesinger, F.; Horling, K.; et al. Detection of ESR1 Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients. Cancers 2025, 17, 1266. https://doi.org/10.3390/ cancers17081266
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: Overall survival and updated 5-year results from the randomized DYNAMIC trial.
Tie J, Cohen JD, Lahouel K, et al. Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer. N Engl J Med. 2022;386(24):2261–2272. doi:10.1056/NEJMoa2200075